134 related articles for article (PubMed ID: 24793456)
41. In vitro study of the photocytotoxicity of bathochromically-shifted hypericin derivatives.
Roelants M; Lackner B; Waser M; Falk H; Agostinis P; Van Poppel H; de Witte PA
Photochem Photobiol Sci; 2009 Jun; 8(6):822-9. PubMed ID: 19492110
[TBL] [Abstract][Full Text] [Related]
42. Overcome the limitation of hypoxia against photodynamic therapy to treat cancer cells by using perfluorocarbon nanodroplet for photosensitizer delivery.
Tang X; Cheng Y; Huang S; Zhi F; Yuan A; Hu Y; Wu J
Biochem Biophys Res Commun; 2017 Jun; 487(3):483-487. PubMed ID: 28359763
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy.
Zhang J; Deng L; Yao J; Gu P; Yang F; Wang X; Liu W; Zhang Y; Ke X; Jing X; Chen J
Bioorg Med Chem; 2011 Sep; 19(18):5520-8. PubMed ID: 21855352
[TBL] [Abstract][Full Text] [Related]
44. Heavy-atomic construction of photosensitizer nanoparticles for enhanced photodynamic therapy of cancer.
Lim CK; Shin J; Lee YD; Kim J; Park H; Kwon IC; Kim S
Small; 2011 Jan; 7(1):112-8. PubMed ID: 21132707
[TBL] [Abstract][Full Text] [Related]
45. Macrophage-targeted photosensitizer conjugate delivered by intratumoral injection.
Anatelli F; Mroz P; Liu Q; Yang C; Castano AP; Swietlik E; Hamblin MR
Mol Pharm; 2006; 3(6):654-64. PubMed ID: 17140253
[TBL] [Abstract][Full Text] [Related]
46. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
47. Zinc coproporphyrin I derived from meconium has an antitumor effect associated with singlet oxygen generation.
Ozawa H; Asahina T; Murakami H; Yaguchi C; Kohmura Y; Kohno E; Hirano T; Horiuchi K; Tamura N; Sugihara K; Ooi H; Kanayama N
Fetal Diagn Ther; 2013; 33(2):90-7. PubMed ID: 23306444
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of β-functionalized temoporfin derivatives for an application in photodynamic therapy.
Aicher D; Gräfe S; Stark CB; Wiehe A
Bioorg Med Chem Lett; 2011 Oct; 21(19):5808-11. PubMed ID: 21885278
[TBL] [Abstract][Full Text] [Related]
49. pH stimulus-disaggregated BODIPY: an activated photodynamic/photothermal sensitizer applicable to tumor ablation.
Liu Y; Xu C; Teng L; Liu HW; Ren TB; Xu S; Lou X; Guo H; Yuan L; Zhang XB
Chem Commun (Camb); 2020 Feb; 56(13):1956-1959. PubMed ID: 31956868
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and in vitro photocytotoxicity of coumarin derivatives for one- and two-photon excited photodynamic therapy.
Zou Q; Fang Y; Zhao Y; Zhao H; Wang Y; Gu Y; Wu F
J Med Chem; 2013 Jul; 56(13):5288-94. PubMed ID: 23763331
[TBL] [Abstract][Full Text] [Related]
51. A new nonconjugated naphthalene derivative of meso-tetra-(3-hydroxy)-phenyl-porphyrin as a potential sensitizer for photodynamic therapy.
Silva P; Fonseca SM; Arranja CT; Burrows HD; Urbano AM; Sobral AJ
Photochem Photobiol; 2010; 86(5):1147-53. PubMed ID: 20553404
[TBL] [Abstract][Full Text] [Related]
52. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system.
Lee SJ; Koo H; Lee DE; Min S; Lee S; Chen X; Choi Y; Leary JF; Park K; Jeong SY; Kwon IC; Kim K; Choi K
Biomaterials; 2011 Jun; 32(16):4021-9. PubMed ID: 21376388
[TBL] [Abstract][Full Text] [Related]
53. Photodynamic properties of meta-tetra(hydroxyphenyl)chlorin in human tumor cells.
Melnikova VO; Bezdetnaya LN; Potapenko AY; Guillemin F
Radiat Res; 1999 Oct; 152(4):428-35. PubMed ID: 10477920
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, photophysical, electrochemical, tumor-imaging, and phototherapeutic properties of purpurinimide-N-substituted cyanine dyes joined with variable lengths of linkers.
Williams MP; Ethirajan M; Ohkubo K; Chen P; Pera P; Morgan J; White WH; Shibata M; Fukuzumi S; Kadish KM; Pandey RK
Bioconjug Chem; 2011 Nov; 22(11):2283-95. PubMed ID: 21985310
[TBL] [Abstract][Full Text] [Related]
55. Imidazole-modified porphyrin as a pH-responsive sensitizer for cancer photodynamic therapy.
Zhu X; Lu W; Zhang Y; Reed A; Newton B; Fan Z; Yu H; Ray PC; Gao R
Chem Commun (Camb); 2011 Oct; 47(37):10311-3. PubMed ID: 21853198
[TBL] [Abstract][Full Text] [Related]
56. Photodynamic therapy and anti-tumor immunity.
Gollnick SO; Owczarczak B; Maier P
Lasers Surg Med; 2006 Jun; 38(5):509-15. PubMed ID: 16788921
[TBL] [Abstract][Full Text] [Related]
57. Targeted photodynamic therapy agent with a built-in apoptosis sensor for in vivo near-infrared imaging of tumor apoptosis triggered by its photosensitization in situ.
Stefflova K; Chen J; Li H; Zheng G
Mol Imaging; 2006; 5(4):520-32. PubMed ID: 17150164
[TBL] [Abstract][Full Text] [Related]
58. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
59. A Tumor-Targeting Dual-Stimuli-Activatable Photodynamic Molecular Beacon for Precise Photodynamic Therapy.
Tam LKB; He L; Ng DKP; Cheung PCK; Lo PC
Chemistry; 2022 Oct; 28(57):e202201652. PubMed ID: 35852020
[TBL] [Abstract][Full Text] [Related]
60. Photodynamic therapy agent with a built-in apoptosis sensor for evaluating its own therapeutic outcome in situ.
Stefflova K; Chen J; Marotta D; Li H; Zheng G
J Med Chem; 2006 Jun; 49(13):3850-6. PubMed ID: 16789741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
